Recombinant Anti-human Aβ Intrabody [Tat]
Recombinant anti-Aβ intrabody in fusion with HIV Tat works within cells to bind amyloidogenic protein fragment Aβ, expressed in 293T cells. Intrabodies have shown efficacy in blocking the toxicity of Aβ in cell culture and paving the way for clinical trials of these reagents in brain disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | IAB-B052(T) |
| Pricing | Inquiry |
| Host | human |
| Target | Aβ |
| Species Reactivity | human |
| Type | scFv-Tat |
| Applications | Formats of immunological tests: Protein fragment complementation; Western blot; Functional studies |
| Storage | 4 °C, -20°C if preferred |